Table 3.
Health Utilities and Disutilities
| Parameter | Value | Reference |
|---|---|---|
| EQ-5D utility | ||
| No response | 0.215 | PULSAR trial23 |
| Partial response | 0.612 | PULSAR trial23 |
| Complete response | 0.680 | PULSAR trial23 |
| Disutilities | ||
| Lung transplant | −0.510 | Anyanwu 200148 |
| Extrapulmonary organ involvement | ||
| Skin | −0.057 | Chen 200449 |
| Cardiac | −0.076 | Di Tanna 202150 |
| Eyes | −0.220 | Brown 200951 |
| Bone or joint | −0.030 | Törmälehto 201852 |
| Liver | −0.130 | Dan 200853 |
| Chronic medication use | ||
| Chronic oral corticosteroid use | −0.023 | ICER 201854 |
| Substance use disorder | −0.132 | ICER 201855 |
| Pain | ||
| Mild | −0.170 | Wetherington 201456 |
| Moderate | −0.400 | Wetherington 201456 |
| Severe | −0.430 | Wetherington 201456 |
| Depression | ||
| Mild | −0.130 | Kolovos 201757 |
| Moderate | −0.180 | Kolovos 201757 |
| Severe | −0.310 | Kolovos 201763 |
Abbreviation: EQ-5D, EuroQol five-dimension.